Literature DB >> 10688360

A tertiary interaction detected in a human U2-U6 snRNA complex assembled in vitro resembles a genetically proven interaction in yeast.

S Valadkhan1, J L Manley.   

Abstract

U2 and U6 small nuclear RNAs are thought to play critical roles in pre-mRNA splicing catalysis. Genetic evidence suggests they form an extensively base-paired structure within the spliceosome that is required for catalysis. Especially in light of significant similarities with group II self-splicing introns, we wished to investigate whether the purified RNAs might by themselves be able to form a complex similar to that which appears to exist in the spliceosome. To this end, we synthesized and purified large segments of human U2 and U6 snRNAs. Upon annealing, the two RNAs efficiently formed a stable and apparently extensively base-paired (Tm = 50-60 degrees C in the presence of 20 mM Mg2+) complex. To investigate possible tertiary interactions, we subjected the annealed complex to UV irradiation, and two crosslinked species were identified and characterized. The major one links the second G in the highly conserved and critical ACAGAGA sequence in U6 with an A in U2 just 5' to U2-U6 helix Ia and opposite the invariant AGC in U6. Remarkably, this crosslink indicates a tertiary interaction essentially identical to one detected previously by genetic covariation in yeast. Together our results suggest that purified U2 and U6 snRNAs can anneal and fold to form a structure resembling that likely to exist in the catalytically active spliceosome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688360      PMCID: PMC1369907          DOI: 10.1017/s1355838200992197

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  58 in total

1.  Catalytically critical nucleotide in domain 5 of a group II intron.

Authors:  C L Peebles; M Zhang; P S Perlman; J S Franzen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 2.  The structure and function of proteins involved in mammalian pre-mRNA splicing.

Authors:  A Krämer
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

3.  Base-pairing interactions involving the 5' and 3'-terminal nucleotides of group II self-splicing introns.

Authors:  A Jacquier; F Michel
Journal:  J Mol Biol       Date:  1990-06-05       Impact factor: 5.469

4.  Two domains of yeast U6 small nuclear RNA required for both steps of nuclear precursor messenger RNA splicing.

Authors:  P Fabrizio; J Abelson
Journal:  Science       Date:  1990-10-19       Impact factor: 47.728

5.  The invariant U5 snRNA loop 1 sequence is dispensable for the first catalytic step of pre-mRNA splicing in yeast.

Authors:  R T O'Keefe; C Norman; A J Newman
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

6.  An RNA conformational change between the two chemical steps of group II self-splicing.

Authors:  G Chanfreau; A Jacquier
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

7.  The canonical GU dinucleotide at the 5' splice site is recognized by p220 of the U5 snRNP within the spliceosome.

Authors:  J L Reyes; P Kois; B B Konforti; M M Konarska
Journal:  RNA       Date:  1996-03       Impact factor: 4.942

8.  The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme.

Authors:  C Guerrier-Takada; K Gardiner; T Marsh; N Pace; S Altman
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

9.  Evidence for base-pairing between mammalian U2 and U6 small nuclear ribonucleoprotein particles.

Authors:  T P Hausner; L M Giglio; A M Weiner
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

10.  Site-specific crosslinks of yeast U6 snRNA to the pre-mRNA near the 5' splice site.

Authors:  C H Kim; J Abelson
Journal:  RNA       Date:  1996-10       Impact factor: 4.942

View more
  21 in total

1.  Sequences upstream of the branch site are required to form helix II between U2 and U6 snRNA in a trans-splicing reaction.

Authors:  G Ast; T Pavelitz; A M Weiner
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

2.  Nuclease protection of RNAs containing site-specific labels: a rapid method for mapping RNA-protein interactions.

Authors:  P A Maroney; C M Romfo; T W Nilsen
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

3.  Characterization of the catalytic activity of U2 and U6 snRNAs.

Authors:  Saba Valadkhan; James L Manley
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

4.  Structure of the yeast U2/U6 snRNA complex.

Authors:  Jordan E Burke; Dipali G Sashital; Xiaobing Zuo; Yun-Xing Wang; Samuel E Butcher
Journal:  RNA       Date:  2012-02-10       Impact factor: 4.942

5.  Mutation in the U2 snRNA influences exon interactions of U5 snRNA loop 1 during pre-mRNA splicing.

Authors:  Joanne C McGrail; Elaine M Tatum; Raymond T O'Keefe
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

6.  Free energy landscapes of RNA/RNA complexes: with applications to snRNA complexes in spliceosomes.

Authors:  Song Cao; Shi-Jie Chen
Journal:  J Mol Biol       Date:  2005-12-21       Impact factor: 5.469

7.  Protein-free spliceosomal snRNAs catalyze a reaction that resembles the first step of splicing.

Authors:  Saba Valadkhan; Afshin Mohammadi; Chaim Wachtel; James L Manley
Journal:  RNA       Date:  2007-10-16       Impact factor: 4.942

8.  The use of simple model systems to study spliceosomal catalysis.

Authors:  Saba Valadkhan; James L Manley
Journal:  RNA       Date:  2008-11-24       Impact factor: 4.942

9.  Protein-free small nuclear RNAs catalyze a two-step splicing reaction.

Authors:  Saba Valadkhan; Afshin Mohammadi; Yasaman Jaladat; Sarah Geisler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

10.  A structural analysis of the group II intron active site and implications for the spliceosome.

Authors:  Kevin S Keating; Navtej Toor; Philip S Perlman; Anna Marie Pyle
Journal:  RNA       Date:  2009-11-30       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.